Evonik has opened a new Asia Beauty Science and Innovation Centre in Shanghai, China, to strengthen its presence across Asia. The facility integrates biotechnology-driven ingredient innovation, formulation expertise, and consumer testing capabilities, directly supporting beauty and personal care brands in China and the broader Asian market. For overseas buyers and distributors, this signals Evonik’s deepened commitment to localized R&D and faster market-ready solutions in a key growth region.
Centre capabilities and supply-chain relevance
The centre houses Evonik’s Asia RD&I Platform, enabling cross-functional activities from molecular design to industrial scale-up. Key capabilities include enzymatic esterification, polyglycerol ester development, and end-to-end functional ingredient innovation. These technologies are directly relevant for OEMs and formulators seeking advanced, sustainable raw materials for skin care, hair care, and color cosmetics.
Applied innovation lab and brand support
The Asia Personal Care Applied Innovation Lab will work closely with brands across skin care, cleansing, hair care, sun care, and color cosmetics. It supports the full development journey from trend insights and formulation design to prototyping, stability assessment, sensory evaluation, efficacy testing, and scientific communication. This integrated service model can reduce time-to-market for new product launches.
Asian skin research and efficacy substantiation
The Chinese lab of the global Evonik Skin Institute will focus on understanding unique characteristics of Asian skin. It offers screening, advanced 3D skin models, clinical study design, state-of-the-art skin imaging, and biomarker analysis. These capabilities provide robust efficacy substantiation and credible product claims, essential for regulatory compliance and consumer trust in Asian markets.
Customer engagement and partnership models
The Customer Experience Centre is a multifunctional space designed to enhance customer engagement. It hosts solution demonstrations, scientific communication co-creation, and explores flexible, collaborative partnership models. This setup allows distributors and clinics to co-develop tailored solutions with Evonik’s technical teams.
What buyers should watch
Overseas importers and clinic buyers should monitor Evonik’s expanded portfolio of bio-based and functional ingredients developed at this centre. The facility’s focus on Asian skin and fast prototyping means suppliers can expect shorter lead times for customized formulations. Partnerships with the Customer Experience Centre may offer early access to new ingredient technologies.
Regulatory and channel signals
The centre reinforces Shanghai’s position as a key innovation hub within Evonik’s global R&D network. For companies sourcing ingredients for the Chinese market, this local presence can facilitate compliance with China’s cosmetic ingredient registration and notification requirements. It also signals Evonik’s long-term commitment to the region, potentially stabilizing supply chains for Asian-focused product lines.
Source: Read the original report | Published: June 03, 2026